Prevention of recurrent staphylococcal skin infections with low-dose oral clindamycin therapy

Clicks: 336
ID: 113900
1988
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
We conducted a double-blind, controlled trial of low-dose (150 mg/d) oral clindamycin hydrochloride vs placebo to prevent recurrent staphylococcal skin infections. Twenty-two patients (11 in both the placebo and clindamycin treatment groups) completed the trial and were assessable. The two groups di …
Reference Key
ms1988jamaprevention Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Klempner MS;Styrt B;;
Journal JAMA
Year 1988
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/3184334
Keywords
Administration National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't adult female male aged middle aged Recurrence Clinical Trial Randomized Controlled Trial Double-Blind Method Random Allocation neutrophils / physiology oral staphylococcal skin infections / prevention & control* pmid:3184334 m s klempner b styrt clindamycin / therapeutic use* staphylococcal skin infections / drug therapy staphylococcal skin infections / immunology

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.